If we do not make treatment more widely available, the number of people who develop liver failure will escalate by 60 to 70 cases a year, rising to 150 a year by 2020.The treatment of HCV involves a combination therapy of pegylated interferon and ribavirin, a course of which costs between £7,000 and £9,000 per patient.